All In Biotech

Drug Trial Radar · NCT05010577

Nebulized Bacteriophage Therapy in Cystic Fibrosis Patients With Chronic Pseudomonas Aeruginosa Pulmonary Infection

A Phase 1b/2a, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Nebulized Bacteriophage Treatment in Outpatient Adult Cystic Fibrosis (CF) Subjects With Chronic Pseudomonas Aeruginosa (PsA) Pulmonary Infection

Last checked: Nov 19, 2026Latest source record: Jul 18, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

43

Actual

Start

Jun 21, 2022

Primary completion

Mar 10, 2024

Study completion Mar 10, 2024

Sponsor

Lead sponsor
BiomX, Inc.Industry
Sponsor type
Industry
First posted
Aug 18, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a Phase 1b/2a study with the primary objective to determine if BX004-A is safe and tolerable. Exploratory objectives include whether BX004-A reduces sputum Pseudomonas aeruginosa (PsA) bacterial load in CF subjects with chronic PsA pulmonary infection.

Conditions

  • Chronic Pseudomonas Aeruginosa Infection
  • Cystic Fibrosis

Interventions

  • BX004-ADrug

    Combination of nebulized bacteriophages targeting Pseudomonas aeruginosa

  • PlaceboDrug

    Nebulized placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety and tolerabilityTime frame: 6 months

Locations

28 sites in 5 countries. Site status is shown where the registry gives one.

  • The University of Alabama at Birmingham

    Birmingham, Alabama

  • Providence Alaska Medical Center

    Anchorage, Alaska

  • University of Arkansas for Medical Sciences

    Little Rock, Arkansas

  • Yale University

    New Haven, Connecticut

  • Children's National Medical Center

    Washington D.C., District of Columbia

  • University of Florida

    Gainesville, Florida

  • Joe DiMaggio Children's Hospital

    Hollywood, Florida

  • Central Florida Pulmonary Group

    Orlando, Florida

  • Boston Children's Hospital

    Boston, Massachusetts

  • New York Medical College

    Valhalla, New York

  • Cincinnati Children's Hospital

    Cincinnati, Ohio

  • University Hospitals Rainbow Babies and Children's Hospital

    Cleveland, Ohio

  • Nationwide Children's Hospital

    Columbus, Ohio

  • Penn State Health Milton S. Hershey Medical Center

    Hershey, Pennsylvania

  • Medical University of South Carolina

    Charleston, South Carolina

  • Baylor College of Medicine, Texas Children Clinic

    Houston, Texas

  • University of Utah

    Salt Lake City, Utah

  • Seattle Children's Hospital

    Seattle, Washington

  • University Hospital in Motol

    Prague, Czechia

  • Rambam Health Care Campus (RHCC) - Ruth Rappaport Children's Hospital

    Haifa, Israel

  • Carmel Medical Center

    Haifa, Israel

  • Hadassah University Medical Center

    Jerusalem, Israel

  • Schneider Children's Medical Center of Israel

    Petach Tikvah, Israel

  • The Chaim Sheba Medical Center

    Ramat Gan, Israel

  • Amsterdam Medical Center

    Amsterdam, Netherlands

  • University Medical Center Utrecht

    Utrecht, Netherlands

  • Vall d'Hebron Barcelona Hospital Campus

    Barcelona, Spain

  • Hospital Clinico Universitario Virgen de la Arrixaca

    El Palmar, Murcia, Spain

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.